Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) General Information

Description

A portfolio of worldwide rights to data set, regulatory filings for CD34 and cell therapy program.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Dublin
  • Ireland
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Lisata Therapeutics
Corporate Office
  • Dublin
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program)‘s full profile, request access.

Request a free trial

Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program)‘s full profile, request access.

Request a free trial

Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) FAQs

  • Where is Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) headquartered?

    Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) is headquartered in Dublin, Ireland.

  • What industry is Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) in?

    Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) a private or public company?

    Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) is a Private company.

  • What is Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program)’s current revenue?

    The current revenue for Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) is .

  • Who are Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program)’s investors?

    Shire (Pharmaceuticals) has invested in Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program).

  • When was Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) acquired?

    Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) was acquired on 06-Mar-2018.

  • Who acquired Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program)?

    Shire (Worldwide Rights To Data Set, Regulatory Filings For CD34+ Cell Therapy Program) was acquired by Lisata Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process